<DOC>
	<DOCNO>NCT01471119</DOCNO>
	<brief_summary>To assess effect safety sublingual Dermatophagoides Farinae Drops adult patient atopic dermatitis allergic sensitization house dust mites.240 adult age 18 60 year atopic dermatitis ( Objective Scoring Atopic Dermatitis , Objective SCORAD 10 40 ) go enrol randomize , double-blind , placebo-controlled study.Sublingual Dermatophagoides Farinae Drops placebo give 9 month addition standard therapy.SCORAD , average anesis interval , rescue medicine DLQI record .</brief_summary>
	<brief_title>Sublingual Immunotherapy Patients With Atopic Dermatitis</brief_title>
	<detailed_description>SCORAD compose skin rash area , severity subjective symptom include pruritus sleep quality.Skin rash area severity score objective SCORAD ( range 0 83 ) .Subjective SCORAD range 0 20 total SCORAD range 0 103 .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Patients either sex , age 18 60 year . Diagnosed atopic dermatitis . Mild moderate AD ( [ SCORAD ] 1O40 ) The result skin prick test dermatophagoides farinae allergen extract preparation positive ( ≥2+ ) Written informed consent subject legal guardian . Female patient childbearing potential must negative pregnant test screening use appropriate method contraception . Dust mites primary allergen . Pregnant , breastfeed woman woman plan pregnant within 1 year . Have concurrent skin disease could interfere study evaluation . Were treat antihistamine topical therapy within 7 day randomization . Have receive systemic corticosteroid , leukotriene receptor antagonists immunosuppressant within 4 week randomization . Have receive phototherapy ( e.g . UVA , UVB ) within 4 week randomization . Have history immune suppress disease ( malignant tumor infection HIV ) , autoimmune disease tuberculosis . Patients impaired liver function ( aspartate aminotransferase and/ alanine aminotransferase level 1.5 time upper limit normal ) , impaired renal function ( serum creatinine＞normal value ) severe disease . Bronchial asthma patient need treatment corticosteroids β agonist ( include injection , oral administration inhalation ) regularly . Patients need take βblockers research . Have receive investigational drug within 3 month prior randomization plan use investigational drug participation study . Have receive immunotherapy dust mite preparation within 3 year prior randomization . Patients severe mental disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>sublingual immunotherapy</keyword>
	<keyword>atopic dermatitis</keyword>
	<keyword>Dermatophagoides Farinae Drops</keyword>
</DOC>